Diabetes technology & therapeutics

The most recent articles from: Diabetes Technol. Ther. August 2007

Diabetes Technol. Ther. · Aug 2007

Randomized Controlled Trial Multicenter Study Clinical Trial

The incretin mimetic exenatide as a monotherapy in patients with type 2 diabetes.

Exenatide is an adjunctive therapy for type 2 diabetes, and preliminary evidence suggests that its glucoregulatory effects may be similar in the absence of oral therapy. ⋯ Exenatide twice-daily monotherapy resulted in glycemic improvements and reductions in body weight comparable to that of exenatide combination therapy with metformin in patients with type 2 diabetes.

explore more… mark as read…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!